The table below shows Amylyx Pharmaceuticals, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
-
-
Cost of revenue
-
$0.00
$0.00
$0.00
$0.00
$8.00K
Gross profit
-
-
-
-
-
-
R&D
$27.61M
$19.86M
$27.22M
$22.12M
$21.24M
$23.35M
SG&A
AMLX annual revenue (10-K history)
Amylyx Pharmaceuticals, Inc. reported annual revenue of $0.00 for fiscal year 2025. That is down 100.0% from $87.37M in fiscal 2024. Over the 5 fiscal years shown, annual revenue declined from $285.00K (FY 2021) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.
